Masimo Corporation  

(Public, NASDAQ:MASI)   Watch this stock  
Find more results for masi
35.59
May 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 19.30 - 36.24
Open     -
Vol / Avg. 0.00/356,472.00
Mkt cap 1.86B
P/E 27.49
Div/yield     -
EPS 1.29
Shares 52.62M
Beta 0.82
Inst. own 83%
Aug 5, 2015
Q2 2015 Masimo Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jun 2, 2015
Masimo Corp Annual Shareholders Meeting - 5:00PM EDT - Add to calendar
May 6, 2015
Q1 2015 Masimo Corp Earnings Call - Webcast
May 6, 2015
Q1 2015 Masimo Corp Earnings Release
Mar 10, 2015
Masimo Corp at ROTH Conference
Mar 4, 2015
Masimo Corp at Raymond James Institutional Investors Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '15) 2015
Net profit margin 12.83% 12.68%
Operating margin 17.72% 17.64%
EBITD margin - 18.07%
Return on average assets 13.95% 14.82%
Return on average equity 26.15% 22.93%
Employees 1,200 -
CDP Score - -

Address

52 Discovery
IRVINE, CA 92618-3105
United States - Map
+1-949-2977000 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive patient monitoring products. It develops, manufactures and markets a patient monitoring solution that incorporates a monitor or circuit board and sensors, including single-patient use, reusable and ReSposable sensors and patient cables. In addition, the Company offers remote alarm/monitoring solutions and software. The Company’s main products include Masimo SET, Masimo SafetyNet and Root. It also provides line filters, cannulas, and mainstream adapters; and wafer epitaxy, foundry, and device fabrication services. The Company sells its products to hospitals, emergency medical response organizations, physician offices, veterinarians, long term care facilities, consumers, and alternate care market through its direct sales force and distributors, as well as to original equipment manufacturer partners.

Officers and directors

Joe E. Kiani Chairman of the Board, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
Mark P. de Raad Chief Financial Officer, Executive Vice President - Finance
Age: 55
Bio & Compensation  - Reuters
Jon Coleman President - Worldwide Sales, Professional Services and Medical Affairs
Age: 51
Bio & Compensation  - Reuters
Rick Fishel President, Worldwide OEM Business & Blood Management
Age: 57
Bio & Compensation  - Reuters
Anand Sampath Chief Operating Officer
Age: 48
Bio & Compensation  - Reuters
Yongsam Lee Executive Vice President, Chief Information Officer
Age: 50
Bio & Compensation  - Reuters
Tom McClenahan Executive Vice President, General Counsel, Corporate Secretary
Age: 42
Bio & Compensation  - Reuters
Paul Jansen Executive Vice President - Business Development
Age: 44
Bio & Compensation  - Reuters
David J. Van Ramshorst Chief Accounting Officer
Age: 54
Bio & Compensation  - Reuters
Steven J. Barker M.D., Ph.D. Director
Age: 70
Bio & Compensation  - Reuters